Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Undisclosed
Therapeutic Area : Oncology
Study Phase : Discovery Platform
Sponsor : CureVac
Deal Size : $33.3 million
Deal Type : Acquisition
Details : An additional application of Frame’s technology is the development of personalized cancer vaccines, thereby leveraging the full antigenic potential of a tumor. CureVac will refocus development of personalized cancer vaccines on an mRNA modality.
Product Name : Undisclosed
Product Type : Undisclosed
Upfront Cash : Undisclosed
August 06, 2022
Lead Product(s) : Undisclosed
Therapeutic Area : Oncology
Highest Development Status : Discovery Platform
Sponsor : CureVac
Deal Size : $33.3 million
Deal Type : Acquisition
Reset All
